Do analysts prefer PARK or TACO?

Park Dental Partners presently has a consensus target price of $28.50, suggesting a potential upside of 24.07%. Given Park Dental Partners' stronger consensus rating and higher probable upside, equities analysts plainly believe Park Dental Partners is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Park Dental Partners 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, PARK or TACO?

Berto Acquisition has lower revenue, but higher earnings than Park Dental Partners. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Park Dental Partners $248.15M 0.42 -$360K $0.74 31.04 Berto Acquisition N/A N/A N/A N/A N/A

Is PARK or TACO more profitable?

Company Net Margins Return on Equity Return on Assets Park Dental Partners N/A N/A N/A Berto Acquisition N/A N/A N/A

Does the media prefer PARK or TACO?

In the previous week, Park Dental Partners had 5 more articles in the media than Berto Acquisition. MarketBeat recorded 8 mentions for Park Dental Partners and 3 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 0.96 beat Park Dental Partners' score of 0.92 indicating that Berto Acquisition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Park Dental Partners 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Berto Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PARK or SBC?

In the previous week, SBC Medical Group had 3 more articles in the media than Park Dental Partners. MarketBeat recorded 11 mentions for SBC Medical Group and 8 mentions for Park Dental Partners. Park Dental Partners' average media sentiment score of 0.92 beat SBC Medical Group's score of 0.01 indicating that Park Dental Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Park Dental Partners 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SBC Medical Group 0 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor ACH or PARK?

In the previous week, Accendra Health had 4 more articles in the media than Park Dental Partners. MarketBeat recorded 12 mentions for Accendra Health and 8 mentions for Park Dental Partners. Park Dental Partners' average media sentiment score of 0.92 beat Accendra Health's score of -0.14 indicating that Park Dental Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accendra Health 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Park Dental Partners 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BDSX or PARK?

In the previous week, Biodesix had 19 more articles in the media than Park Dental Partners. MarketBeat recorded 27 mentions for Biodesix and 8 mentions for Park Dental Partners. Biodesix's average media sentiment score of 1.00 beat Park Dental Partners' score of 0.92 indicating that Biodesix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 9 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Park Dental Partners 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to INFU or PARK?

In the previous week, Park Dental Partners had 6 more articles in the media than InfuSystem. MarketBeat recorded 8 mentions for Park Dental Partners and 2 mentions for InfuSystem. Park Dental Partners' average media sentiment score of 0.92 beat InfuSystem's score of 0.00 indicating that Park Dental Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Park Dental Partners 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Park Dental Partners (PARK) Competitors

$22.97 -0.08 (-0.35%)

Closing price 03:59 PM Eastern

Extended Trading

$22.98 +0.01 (+0.04%)

As of 05:29 PM Eastern

Compare

PARK vs. TACO, SBC, ACH, BDSX, and INFU

Should you buy Park Dental Partners stock or one of its competitors? Park Dental Partners's main competitors and comparable companies include Berto Acquisition (TACO), SBC Medical Group (SBC), Accendra Health (ACH), Biodesix (BDSX), and InfuSystem (INFU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Park Dental Partners compare to Berto Acquisition?

Park Dental Partners (NASDAQ:PARK) and Berto Acquisition (NASDAQ:TACO) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

Park Dental Partners presently has a consensus target price of $28.50, suggesting a potential upside of 24.07%. Given Park Dental Partners' stronger consensus rating and higher probable upside, equities analysts plainly believe Park Dental Partners is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Park Dental Partners had 5 more articles in the media than Berto Acquisition. MarketBeat recorded 8 mentions for Park Dental Partners and 3 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 0.96 beat Park Dental Partners' score of 0.92 indicating that Berto Acquisition is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Park Dental Partners	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Berto Acquisition	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Park Dental Partners	N/A	N/A	N/A
Berto Acquisition	N/A	N/A	N/A

Berto Acquisition has lower revenue, but higher earnings than Park Dental Partners.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Park Dental Partners	$248.15M	0.42	-$360K	$0.74	31.04
Berto Acquisition	N/A	N/A	N/A	N/A	N/A

Summary

Park Dental Partners beats Berto Acquisition on 6 of the 7 factors compared between the two stocks.

How does Park Dental Partners compare to SBC Medical Group?

Park Dental Partners (NASDAQ:PARK) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

In the previous week, SBC Medical Group had 3 more articles in the media than Park Dental Partners. MarketBeat recorded 11 mentions for SBC Medical Group and 8 mentions for Park Dental Partners. Park Dental Partners' average media sentiment score of 0.92 beat SBC Medical Group's score of 0.01 indicating that Park Dental Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Park Dental Partners	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SBC Medical Group	0 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Park Dental Partners presently has a consensus price target of $28.50, indicating a potential upside of 24.07%. SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 132.24%. Given SBC Medical Group's higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SBC Medical Group has a net margin of 24.09% compared to Park Dental Partners' net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Park Dental Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Park Dental Partners	N/A	N/A	N/A
SBC Medical Group	24.09%	15.90%	11.61%

60.8% of SBC Medical Group shares are owned by institutional investors. 10.6% of Park Dental Partners shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

SBC Medical Group has lower revenue, but higher earnings than Park Dental Partners. SBC Medical Group is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Park Dental Partners	$248.15M	0.42	-$360K	$0.74	31.04
SBC Medical Group	$173.61M	2.16	$50.99M	$0.39	9.38

Summary

SBC Medical Group beats Park Dental Partners on 10 of the 16 factors compared between the two stocks.

How does Park Dental Partners compare to Accendra Health?

Accendra Health (NYSE:ACH) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

In the previous week, Accendra Health had 4 more articles in the media than Park Dental Partners. MarketBeat recorded 12 mentions for Accendra Health and 8 mentions for Park Dental Partners. Park Dental Partners' average media sentiment score of 0.92 beat Accendra Health's score of -0.14 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accendra Health	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Park Dental Partners	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Accendra Health presently has a consensus price target of $1.50, indicating a potential upside of 58.66%. Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 24.07%. Given Accendra Health's higher possible upside, research analysts plainly believe Accendra Health is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Park Dental Partners has lower revenue, but higher earnings than Accendra Health. Accendra Health is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accendra Health	$2.73B	0.03	-$1.10B	-$3.91	N/A
Park Dental Partners	$248.15M	0.42	-$360K	$0.74	31.04

Park Dental Partners has a net margin of 0.00% compared to Accendra Health's net margin of -11.41%. Park Dental Partners' return on equity of 0.00% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accendra Health	-11.41%	-4.24%	0.65%
Park Dental Partners	N/A	N/A	N/A

Summary

Park Dental Partners beats Accendra Health on 10 of the 14 factors compared between the two stocks.

How does Park Dental Partners compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

21.0% of Biodesix shares are held by institutional investors. 23.2% of Biodesix shares are held by insiders. Comparatively, 10.6% of Park Dental Partners shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Biodesix presently has a consensus price target of $31.33, indicating a potential upside of 30.56%. Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 24.07%. Given Biodesix's stronger consensus rating and higher possible upside, equities research analysts clearly believe Biodesix is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Biodesix had 19 more articles in the media than Park Dental Partners. MarketBeat recorded 27 mentions for Biodesix and 8 mentions for Park Dental Partners. Biodesix's average media sentiment score of 1.00 beat Park Dental Partners' score of 0.92 indicating that Biodesix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	9 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Park Dental Partners	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Park Dental Partners has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$88.50M	2.86	-$35.26M	-$3.17	N/A
Park Dental Partners	$248.15M	0.42	-$360K	$0.74	31.04

Park Dental Partners has a net margin of 0.00% compared to Biodesix's net margin of -26.97%. Park Dental Partners' return on equity of 0.00% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-26.97%	-788.19%	-30.33%
Park Dental Partners	N/A	N/A	N/A

Summary

Biodesix beats Park Dental Partners on 8 of the 15 factors compared between the two stocks.

How does Park Dental Partners compare to InfuSystem?

InfuSystem (NYSE:INFU) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

InfuSystem currently has a consensus price target of $16.67, suggesting a potential upside of 35.83%. Park Dental Partners has a consensus price target of $28.50, suggesting a potential upside of 24.07%. Given InfuSystem's stronger consensus rating and higher probable upside, analysts plainly believe InfuSystem is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

71.1% of InfuSystem shares are owned by institutional investors. 10.8% of InfuSystem shares are owned by company insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

InfuSystem has higher earnings, but lower revenue than Park Dental Partners. InfuSystem is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$143.34M	1.73	$870K	$0.41	29.93
Park Dental Partners	$248.15M	0.42	-$360K	$0.74	31.04

InfuSystem has a net margin of 1.12% compared to Park Dental Partners' net margin of 0.00%. InfuSystem's return on equity of 2.78% beat Park Dental Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
Park Dental Partners	N/A	N/A	N/A

In the previous week, Park Dental Partners had 6 more articles in the media than InfuSystem. MarketBeat recorded 8 mentions for Park Dental Partners and 2 mentions for InfuSystem. Park Dental Partners' average media sentiment score of 0.92 beat InfuSystem's score of 0.00 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InfuSystem	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Park Dental Partners	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

InfuSystem beats Park Dental Partners on 11 of the 16 factors compared between the two stocks.

Get Park Dental Partners News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PARK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PARK vs. The Competition

Export

Metric	Park Dental Partners	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$103.71M	$9.87B	$6.98B	$13.04B
Dividend Yield	N/A	2.55%	2.58%	10.72%
P/E Ratio	31.04	34.92	269.56	25.30
Price / Sales	0.42	4.80	598.74	101.64
Price / Cash	4.76	124.00	70.53	50.75
Price / Book	4.31	5.35	13.08	6.33
Net Income	-$360K	$309.96M	$3.45B	$347.70M
7 Day Performance	8.55%	0.28%	1.11%	1.06%
1 Month Performance	14.62%	0.68%	1.79%	1.03%
1 Year Performance	N/A	20.38%	67.70%	20.73%

Park Dental Partners Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PARK Park Dental Partners	3.2979 of 5 stars	$22.97 -0.3%	$24.50 +6.7%	N/A	$103.71M	$248.15M	31.04	1,212	Analyst Forecast Short Interest Increase
TACO Berto Acquisition	1.5812 of 5 stars	$10.44 +0.0%	N/A	+1.6%	$340.39M	N/A	N/A	7,892	News Coverage Positive News Short Interest Decrease
SBC SBC Medical Group	3.4181 of 5 stars	$3.17 +0.2%	$8.50 +168.6%	-26.2%	$324.67M	$173.61M	8.12	N/A	Trending News Earnings Report Analyst Forecast
ACH Accendra Health	2.6697 of 5 stars	$3.27 -4.1%	$5.00 +52.9%	N/A	$250.42M	$2.73B	N/A	6,500	Earnings Report Analyst Downgrade
BDSX Biodesix	4.6323 of 5 stars	$22.87 +3.8%	$28.33 +23.9%	+210.2%	$236.36M	$88.50M	N/A	220	News Coverage Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PARK) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Park Dental Partners (PARK) Competitors

PARK vs. TACO, SBC, ACH, BDSX, and INFU

How does Park Dental Partners compare to Berto Acquisition?

Summary

How does Park Dental Partners compare to SBC Medical Group?

Summary

How does Park Dental Partners compare to Accendra Health?

Summary

How does Park Dental Partners compare to Biodesix?

Summary

How does Park Dental Partners compare to InfuSystem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PARK vs. The Competition

Park Dental Partners Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Park Dental Partners (PARK) Competitors

PARK vs. TACO, SBC, ACH, BDSX, and INFU

How does Park Dental Partners compare to Berto Acquisition?

Do analysts prefer PARK or TACO?

Does the media prefer PARK or TACO?

Is PARK or TACO more profitable?

Which has higher earnings and valuation, PARK or TACO?

Summary

How does Park Dental Partners compare to SBC Medical Group?

Does the media favor PARK or SBC?

Do analysts rate PARK or SBC?

Is PARK or SBC more profitable?

Do insiders & institutionals have more ownership in PARK or SBC?

Which has higher valuation and earnings, PARK or SBC?

Summary

How does Park Dental Partners compare to Accendra Health?

Does the media favor ACH or PARK?

Do analysts recommend ACH or PARK?

Which has preferable earnings and valuation, ACH or PARK?

Is ACH or PARK more profitable?

Summary

How does Park Dental Partners compare to Biodesix?

Do insiders & institutionals hold more shares of BDSX or PARK?

Do analysts recommend BDSX or PARK?

Does the media prefer BDSX or PARK?

Which has better valuation and earnings, BDSX or PARK?

Is BDSX or PARK more profitable?

Summary

How does Park Dental Partners compare to InfuSystem?

Do analysts rate INFU or PARK?

Do insiders and institutionals hold more shares of INFU or PARK?

Which has better valuation and earnings, INFU or PARK?

Is INFU or PARK more profitable?

Does the media refer more to INFU or PARK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PARK vs. The Competition

Park Dental Partners Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools